Update re Bilateral Investment Treaty Claim

RNS Number : 5778L
Pathfinder Minerals Plc
04 January 2023
 

4 January 2023

 

Pathfinder Minerals Plc

("Pathfinder" the "Company")

 

Update re Bilateral Investment Treaty Claim:

Extension of Option Agreement for the Sale of IM Minerals and the Claim

 

Further to the Company's announcement on 29 September 2022 regarding the exclusive option agreement with Acumen Advisory Group LLC ("AAG") for the sale of IM Minerals Limited, a wholly owned subsidiary of the Company (the "Option Agreement"), Pathfinder announces that the Option Agreement has been extended until 31 January 2023 to enable AAG to complete due diligence.  

 

The Option Agreement includes the assignment of the rights to bring a claim against the Government of Mozambique under the Mozambique-United Kingdom Bilateral Investment Treaty (2004) for the expropriation of Mining Concession 4623C.

 

Peter Taylor, Chief Executive Officer of Pathfinder, commented:

 

"We continue to work with AAG towards the potential monetisation of the Company's valuable claim against the Government of Mozambique."

 

Enquiries:

 

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44  +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Abigail Wennington

Tel. +44 (0)20 7409 3494

 

Vigo Consulting (Investor Relations)

Ben Simons / Kate Kilgallen

Tel. +44 (0)20 7390 0234

Email pathfinderminerals@vigoconsulting.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKNBKKBKBBDK
UK 100